Want to see NRIX full AI Analyst Report?
Nurix Therapeutics (NRIX) Q3 2026 Earnings Report
NRIX Q3 2026 EPS Results
- Actual EPS
- $4.73
- Consensus EPS
- -$0.60
- Beat/Miss
- Beat by +$5.33
- One Year Ago EPS
- -$1.03
NRIX Q3 2026 Revenue Results
- Actual Revenue
- $673.06M
- Expected Revenue
- $24.35M
- Beat/Miss
- Beat by +$648.72M
- YoY Revenue Growth
- +8426.27%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/12/2026
- Time
- After Close
- Conference Call
- Monday, October 12, 2026
NRIX Upcoming Earnings
Nurix Therapeutics's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
NRIX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2026 (Q4) | -0.41- | -0.82 | ― | ― |
| Oct 12, 2026 | 2026 (Q3) | -0.604.73 | -1.03 | 559.22% (+5.76) | |
| Jul 09, 2026 | 2026 (Q2) | -0.72-0.81 | -0.52 | -55.77% (-0.29) | |
| Apr 08, 2026 | 2026 (Q1) | -0.76-0.79 | -0.67 | -17.91% (-0.12) | |
| Jan 28, 2026 | 2025 (Q4) | -0.87-0.82 | -0.75 | -9.33% (-0.07) | |
| Oct 09, 2025 | 2025 (Q3) | -0.82-1.03 | -0.67 | -53.73% (-0.36) | |
| Jul 09, 2025 | 2025 (Q2) | -0.72-0.52 | -0.71 | 26.76% (+0.19) | |
| Apr 08, 2025 | 2025 (Q1) | -0.76-0.67 | -0.76 | 11.84% (+0.09) | |
| Jan 28, 2025 | 2024 (Q4) | -0.69-0.75 | -0.77 | 2.60% (+0.02) | |
| Oct 11, 2024 | 2024 (Q3) | -0.69-0.67 | -0.68 | 1.47% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
